A Non-targeted Proteomics Newborn Screening Platform for Genetic Disorders
Shibata, H.; Nakajima, D.; Konno, R.; Hijikata, A.; Higashiguchi, M.; Nihira, H.; Shimodera, S.; Miyamoto, T.; Nishitani-Isa, M.; Hiejima, E.; Izawa, K.; Takita, J.; Heike, T.; Okamura, K.; Ohnishi, H.; Ishimura, M.; Okada, S.; Yamashita, M.; Morio, T.; Kanegane, H.; Imai, K.; Nakamura, Y.; Nonoyama, S.; Uchiyama, T.; Onodera, M.; Nishikomori, R.; Ohara, O.; Kawashima, Y.; Yasumi, T.
Show abstract
Newborn screening using dried blood spot (DBS) samples has made a substantial contribution to public healthcare by detecting patients with genetic disorders as neonates. Targeted measurements of nucleic acids and metabolites have played major roles in newborn screening to date, while the feasibility of new non-targeted approaches, including genome-wide DNA sequencing, has been explored. Here, we investigated the applicability of non-targeted quantitative proteomics analysis to newborn screening for genetic diseases. DBS protein profiling allowed monitoring of levels of proteins encoded by 2912 genes, including 1106 listed in the Online Mendelian Inheritance in Man database, in healthy newborn samples, and was useful in identifying patients with inborn errors of immunity by detecting reduced levels of disease causative proteins and cell-phenotypical alterations. Our results indicate that application of non-targeted quantitative protein profiling of DBS samples can forge a new path in screening for genetic disorders.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deep proteomics network and machine learning analysis of human cerebrospinal fluid in Japanese encephalitis virus infection 93%
- Massive proteogenomic reanalysis of publicly available proteomic datasets of human tissues in search for protein recoding via adenosine-to-inosine RNA editing 92%
- Defining the Caprin-1 interactome in unstressed and stressed conditions 92%
Similar papers in this journal
- Tagless LysoIP method for molecular profiling of lysosomal content in clinical samples 92%
- Identification of novel biomarkers for pyridoxine-dependent epilepsy using untargeted metabolomics and infrared ion spectroscopy - biochemical insights and clinical implications 92%
- A human multisystem disorder with autoinflammation, leukoencephalopathy and hepatopathy is caused by mutations in C2orf69 92%
Similar papers in this journal
- Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes and normal tissues 94%
- Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 93%
- Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity 92%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.